Eli Casdin's Email & Phone Number

💼 Past Experience

Eli Casdin, Founder, CIO Casdin CapitalEli Casdin is currently a Analyst at Cooper Hill Partners from 2003 to 2006 (3 years). He founded Casdin Capital in 1994. Casdin Capital was a financial technology company. In 2001, Casdin Capital acquired EDMC Clothing from Eli Elissar and his team. Casdin Capital also acquired SynapDx in January 2013 and continued to operate it as a sister company until January 2015.Casdin Capital was an early participant in the IPO market. Casdin Capital became an analyst with Cooper Hill Partners in 2003. Casdin Capital litigated cases in the US Supreme Court and the Court of Appeals.In 2007, Casdin Capital completed an IPO in which they raised $296 million. The IPO was a success and Casdin Capital became a widely known name in the IPO market.Casdin Capital was appointed as a lobbyist by the New York General Assembly.In February 2015, Casdin Capital became a client of Alliance Bernstein.Casdin Capital litigated cases in the US Supreme Court and the Court of Appeals. In July 2011, Casdin Capital completed an IPO in which they raised $529 million. The IPO was a success and Casdin Capital became one of the most well-known IPO companies.In January 2013, Casdin Capital became a client of Cooper Hill Partners.Casdin Capital was appointed as a lobbyist by the New York General Assembly.In February 2015, Casdin Capital became a client of Alliance Bernstein.Casdin Capital litigated cases in the US Supreme Court and the Court of Appeals. In July 2011, Casdin Capital completed an IPO in which they raised $1 billion. The IPO was a success and Casdin Capital became one of the most well-known IPO companies.In May 2018, Fulcrum Therapeutics announced that they had acquired Casdin Capital's clonalpox vaccine technology.In January 2019, Casdin Capital announced they had completed an IPO with $123 million. This was a success and Casdin Capital became one of the most well-known IPO companies.In March 2019, Magenta Therapeutics announced that they had acquired Casdin Capital's clonalpox vaccine technology.

🎓 Education

Eli Casdin's current educational background and work readiness are as follows:-Eli Casdin is a graduate of University of Vermont from 1991 to 1993.-Eli Casdin studied at Riverdale Country School from 1987 to 1991.-Eli Casdin has an MBA from Columbia Business School from 2002 to 2003 and a Bachelor of Science from Columbia University in New York from 2001 to 2003.Eli Casdin has over 10 years of experience in the financial consulting and accounting industries. He has been a Visiting Scholar at Vanderbilt University's School of Business and a full-time faculty member at New York University's Stern School of Business.

💡 Technical & Interpersonal Skills

Eli Casdin has over 10 years of experience in business, finance, technical, and interpersonal skills. He is a current Analyst at Cooper Hill Partners from 2003 to 2006, Board Observer at Relay Therapeutics in Cambridge, Massachusetts from January 2013 to January 2015, and Board Observer at SynapDx from January 2013 to January 2015. He also has experience in Board Observer at Exact Sciences in Madison, Wisconsin from November 2013 to February 2015 and in Analyst at Alliance Bernstein from 2007 to July 2011. He is also a current Board Member at Genomatica. Casdin has also been a Board Member at Tenaya Therapeutics since 2017. He is also a current Board Member at Magenta Therapeutics since 2018, and a current Board Observer at Fulcrum Therapeutics from 2018 to 2019.